Hydrotreatment catalyst, method for the preparation thereof, and use of the same

Details for Australian Patent Application No. 2006207426 (hide)

Owner IFP Total Raffinage Marketing

Inventors Fremy, Georges; Cholley, Thierry; Humblot, Francis; Dath, Jean-Pierre; Brun, Claude

Agent Watermark

Pub. Number AU-B-2006207426

PCT Pub. Number WO2006/077302

Priority 0500577 20.01.05 FR

Filing date 19 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 29 July 2010

International Classifications

B01J 23/88 (2006.01) Catalysts comprising metals or metal oxides or hydroxides, not provided for in group

B01J 23/94 (2006.01) Catalysts comprising metals or metal oxides or hydroxides, not provided for in group

B01J 37/20 (2006.01) Processes, in general, for preparing catalysts

B01J 38/52 (2006.01) Regeneration or reactivation of catalysts, in general

C10G 45/08 (2006.01) Hydrotreatment processes

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077302 Priority application(s): WO2006/077302

29 January 2009 Alteration of Name

  The name of the applicant has been altered to Arkema France; Total Raffinage Marketing

3 June 2010 Assignment before Grant

  Total Raffinage Marketing; Arkema France The application has been assigned to Total Raffinage Marketing; IFP

29 July 2010 Application Accepted

  Published as AU-B-2006207426

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207440-Method for analyzing oligosaccharides from blood plasma

2006207396-Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof